<DOC>
	<DOCNO>NCT02256774</DOCNO>
	<brief_summary>Study determine effect BILR 355/r Combivir® pharmacokinetics effect Combivir® BILR 355 BS pharmacokinetics .</brief_summary>
	<brief_title>Study Pharmacokinetic Interaction Between Combivir® ( ZDV+3TC ) BILR 355 BS Plus Ritonavir Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lamivudine , zidovudine drug combination</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>1 . Males females meet inclusion/exclusion criterion , female pregnant nursing , agree use doublebarrier method birth control ( condom diaphragm plus spermicide ) throughout trial ( alone addition method birth control oral contraceptive ) 2 . Age ≥18 &lt; 60 year 3 . Body Mass Index ( BMI ) ≥18.5 BMI ≤29.9 kg/m2 4 . Ability give sign dated write informed consent prior admission study accordance Good Clinical Practice local regulation 1 . Current ( symptomatic within last 30 day ) medically relevant gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 2 . Surgery gastrointestinal tract ( except appendectomy ) 3 . Currently active ( symptomatic within last 30 day ) diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 4 . History relevant orthostatic hypotension , faint spell blackouts 5 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator 6 . Intake drug long halflife ( &gt; 24 hour ) within one month prior administration study drug trial ( review clinical monitor questionable ) 7 . Use drug within 10 day prior administration trial , might reasonably influence result trial base knowledge time protocol preparation ( review clinical monitor questionable ) 8 . Participation another trial investigational drug within one month prior administration trial 9 . Current smoker 10 . Alcohol ( 60 g/day ) drug abuse ( positive urine test illicit prescription nonprescription drug drug abuse ) . 11 . Recent blood donation ( 100 mL within 4 week prior administration trial ) 12 . Excessive physical activity ( within 1 week prior study drug administration trial ) 13 . Any laboratory value outside normal reference range clinical relevance screening , accord judgment investigator 14 . Inability comply dietary regimen require protocol 15 . Chronic relevant acute infection 16 . Infected hepatitis B hepatitis C virus ( define either hepatitis B surface antigen , hepatitis C antibody positive ) 17 . HIV1 infect define positive HIV ELISA test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>